1. Home
  2. Companies
  3. Main Sequence
MS

Main Sequence

About

Unreasonable inventors are combining cutting edge scientific discoveries with the world's biggest challenges to build the next generation of global companies.

These are the companies we create and invest in at Main Sequence.

  • We have over $500m under management from lean-in LPs who help our portfolio to prosper.
  • We are investing in the difficult to build companies others struggle to support.
  • Our co-founder is Australia's $1.3b annual budget science agency - CSIRO
  • We invest from seed to Series B, starting our journey as early as possible, driving advantage into our portfolio.

Our Advantage

Deep tech inventors need more. We have custom built Main Sequence to be ready to help you solve some of the world's greatest challenges with science.

We are hands-on and have built a services offering to support founders alongside our capital.

Our story

Main Sequence was created by CSIRO to address the ‘valley of death’ between research and commercialisation. It solves the world’s greatest challenges by turning our scientific breakthroughs into the next century’s giants.

Main Sequence’s origins within CSIRO reflect its commitment to amplifying connections between industry, research and infrastructure to accelerate deep technology development, and reinvesting economic returns from commercialisation back into science.

CSIRO Innovation Funds 1 and 2 managed by Main Sequence, have invested in 39 companies since establishment in 2017. These companies have created over 1,200 jobs by working with partners in industry, CSIRO, and 22 Australian universities.

The $240 million first CSIRO Innovation Fund , built on a cornerstone investment by government and CSIRO has completed its portfolio and invested in 27 companies since establishment in 2017.

The second $300 million CSIRO Innovation Fund commenced investing mid-2021 and had already invested in 12 companies by the end of 2021.

Following the Government’s announcement on 1 February 2022 of a reform agenda to accelerate commercialisation of research and collaboration with industry, including $150m support for CSIRO investment in future CSIRO Innovation Funds, Main Sequence welcomes the opportunity to continue to work closely with universities to commercialise Australian research and build Australian companies addressing global challenges.

Each of our portfolio companies has some advantage delivered by either one of Australia's 43 universities or an industrial research organisation such as CSIRO.

In some cases this exists before we invest, in others we facilitate it as part of the companies pathway to scale and impact.

Similar companies

SV

Starlight Ventures

We partner early with unstoppable entrepreneurs leveraging breakthrough science and technology to pursue progress at scale. Everything we do revolves around a single problem: What are the best ways to reconcile economic growth with human and planetary health? We invest in teams and solutions that address multi-decade problems that humanity has no choice but to solve. Our focusing questionsHow can we decouple improving living standards from resource depletion? How can we ensure food, energy and materials supply security when confronted by deglobalization, multipolarity and the distractions of the attention economy? How can we improve life on Earth and unlock future economic growth potential by leveraging next-generation computing and exploring outer space? How can the clean industrialization of biological processes reduce humanity’s impact on our planet? How we invest in unstoppable founders We look to problems and unmet needs first and then to which technologies and solutions have the potential to address those problems effectively. We don’t push any one type of technology or limit ourselves to one field. We look for founders and companies at the pre-seed and seed stages leveraging the three basic disciplines (physics, chemistry, biology) to engineer economically viable solutions. We look for teams that are uniquely suited to address the opportunity and its inherent challenges and for solutions that are radically better, technically viable, and defensible. Some of the areas we are keen to continue exploring include clean commodities, space technology, industrial decarbonization, electro- and green chemistry, next-generation computing, new materials & production methods. How we partner for the long-term Starlight is a Pre-Seed and Seed investor and ideally the first institutional check into your company. Having been in your shoes as founders and scientists ourselves, we will serve as an ally in the journey ahead. Here’s what you can expect from working with us: We will lead or co-lead your first institutional round. We reserve capital for follow-on investment in later rounds, and we have to ability to partner with our LPs to augment our participation in future opportunities. We will be personally invested in your success, as a large portion of our fund comes from our own team. We will put a particular focus on ensuring that your roadmap is focused on the key risks and milestones unique to addressing the most pressing problems. We will work with you to establish rock-solid governance and operational practices that hold up to the scrutiny of the world’s best institutional investors. We will help you line up and credibly engage the right future investors for your business and trajectory. Let’s partner and make change happen.

CO

Compound

We use our domain expertise, network, and prior experiences to help our founders scale commercialization, product, and engineering. Post-science project investing We recognize that starting and building a company is hard. Startups by definition are outliers being built by unique collections of humans. We utilize our deep domain expertise to uniquely understand the problems of companies in the categories we care about. Pairing this with our experience working with deep technology, allows us to provide leverage in taking a company from pre, to post-commercialization and building engineering teams across both research and production-level eng.

OX

Oxygea

Oxygea is here to accelerate and invest in people and their business that will drive sustainable innovation and digital transformation. We value ecosystems and we cooperate with local and global networks to provide only the best to startups that will transform the future of the industry. Where do we invest? Circular Economy Technologies intended for reintegrating plastic waste to production chain Extend the useful lifecycle of plastic applications A reduction in the need for production, use, or disposal Carbon Neutrality Energy transition New materials from renewable sources Carbon market CO2 capture, storage and utilization for new chemicals Biotechnology/ Nanotechnology and New Materials New biological and biochemical routes to produce chemicals, plastics and materials Advanced Materials Digital technologies for accelerating R&D developments Plastic as sustainable solution Biopolymers Plastic applications with performance gain Additive manufacturing Smart Factory & Future Mobility Industry 4.0: Analytics, automation and advanced manufacturing technologies Logistics 4.0: Logistics efficiency and improved traceability

IN

Industrifonden

Industrifonden is a venture capital fund backing transformative ventures with the power to change the way we live for the better. We look for unique, scalable innovations that have a meaningful impact on our society. Industrifonden was founded by the Swedish government in 1979 as an independent foundation to provide Swedish industry with an innovation growth engine. For more than forty years, we have partnered with high-tech ventures in deep tech, life science, and transformative business. Today, we are an independent venture capital fund continuing our legacy by partnering with innovators and entrepreneurs to bring Nordic breakthrough innovations to the world. We partner with passionate founders that can turn their ideas into reality and change the industry – or create a totally new one. We primarily invest in Swedish innovations, as well as the Life Science and Deep Tech industries across the Nordics. At Industrifonden, we focus less on short-term wins and more on successful long-term investments that will create lasting value and benefits to our society. We’re in it for the long run, because experience has taught us that developing fundamental innovations takes time. Our areas of expertiseDeep Tech: We invest in advanced technology that addresses important societal issues. We have a special interest in advanced materials, industry 4.0, energy, advanced computing, AI, and synthetic biology. Life science: We invest in the commercialization of products and services, grounded in solid science, which address an unmet medical need. We have expertise in biotech, medtech and healthtech. Transformative tech: We invest in transformative tech and business models to create the industry of tomorrow. We mostly stay within the B2B space but invest in a broad range of industry verticals. Seed to A-round funding We invest in early-stage companies, from seed to A-round funding, and sometimes earlier. Our first ticket is often 10-50 million SEK, with the capacity to invest considerably more during the lifecycle. Smaller tickets are also considered in an earlier stage for exceptional technologies. In it for the long run Our fund has an evergreen structure allowing us to focus less on short-term wins and focus more on investments that will create long-term value. What we look for Unique, scalable innovations that have a meaningful impact on our society. Passionate founders that can turn their ideas into reality. Ideas with the potential to change a whole industry – or create a new one. If this sounds like you, share your pitch deck with us! Your pitch deck should include a clear problem statement, unique solution, target market, business model, team, financial projections, roadmap, cap-table and a clear ask. We value creativity, innovation, and collaboration.

CD

Creative Destruction Lab

CDL has designed a new approach to enterprising research and innovation, nurturing an entrepreneurial mindset through expert opinion, funding opportunities, research analysis, and business development support. CDL’s objective-setting process enhances the performance of technical founders who learn from the insights of experienced entrepreneurs, increasing their probability of success. The Program involves:Mentorship from select entrepreneurs and angel investors: the Fellows and Associates Intensive full-day sessions with the CDL Mentors take place every eight weeks with the purpose of assessing progress and setting new short-term objectives. Fellows and Associates provide professional judgment (entrepreneurial knowledge) to help guide CDL Ventures and prioritize actions. The program is designed for early-stage, science-based technology companies, though we consider all applicants based on their potential to scale and the viability of their product. CDL’s objective-setting process enhances the performance of technical founders who learn from the insights of experienced entrepreneurs, increasing their probability of success. Opportunities to raise capital CDL Mentors are made up of a carefully selected group of exited entrepreneurs, angel investors, and partners from leading venture capital firms. These participants often invest in ventures that demonstrate a track record of achieving their objectives. Advice on technology roadmaps from CDL’s Chief Scientists World-renowned experts from leading academic institutions provide technical feedback to founders and advise the Fellows and Associates on objectives related to technology validation. Business development support from top students Business school students work to support ventures including developing financial models, evaluating potential markets, and fine-tuning strategies for scaling. Twelve locations globally CDL operates five sites in Canada, three in the United States and four in Europe. Launched in 2012 at the Rotman School of Management at University of Toronto, the program has now expanded with locations in Oxford (Saïd Business School, University of Oxford), Paris (HEC Paris), Atlanta (Scheller College of Business, Georgia Institute of Technology), Madison (Wisconsin School of Business, University of Wisconsin-Madison), Seattle (University of Washington, Foster School of Business), Berlin (European School of Management and Technology), Tartu (Delta Management School, University of Tartu), Vancouver (Sauder School of Business, University of British Columbia), Montreal (HEC Montréal), Calgary (Haskayne School of Business, University of Calgary), and Halifax (Rowe School of Business, Dalhousie University).

EL

elev8.vc

elev8.vc is a B2B focused VC Fund based in Singapore, with interests globally. We invest in and support early-stage deep tech founders (up to Series A), to scale their businesses globally.